Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Oleg Ganichkin

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Acta Crystallographica. Section D, Biological Crystallography|September 21, 2007
Conformational switches in winged-helix domains 1 and 2 of bacterial translation elongation factor SelBOleg Ganichkin, Markus C Wahl
Nature Communications|October 28, 2022
Chemical space docking enables large-scale structure-based virtual screening to discover ROCK1 kinase inhibitorsPaul Beroza, James J Crawford, Oleg Ganichkin, et al.
Mabs|October 15, 2024
CD200R1 immune checkpoint blockade by the first-in-human anti-CD200R1 antibody 23ME-00610: molecular mechanism and engineering of a surrogate antibodyCristina Melero, S Jimmy Budiardjo, Anahita Daruwalla, et al.
The Journal of Biological Chemistry|October 8, 2023
Biophysical and structural characterization of the impacts of MET phosphorylation on tepotinib bindingUlrich Grädler, Daniel Schwarz, Ansgar Wegener, et al.
ACS Medicinal Chemistry Letters|September 17, 2025
Discovery of Novel Isofunctional SARS-CoV‑2 NSP14 RNA Cap Methyltransferase Inhibitors by Structure-Based Virtual ScreeningCindy Meyer, Mayako Michino, David J Huggins, et al.
Nature Methods|August 4, 2015
ProteoPlex: stability optimization of macromolecular complexes by sparse-matrix screening of chemical spaceAshwin Chari, David Haselbach, Jan-Martin Kirves, et al.
Journal of Medicinal Chemistry|September 5, 2025
Discovery, Optimization, and Evaluation of Non-Nucleoside SARS-CoV-2 NSP14 InhibitorsMichael W Miller, Cindy Meyer, Aitor Garzia, et al.
Nature|December 11, 2024
Small-molecule inhibition of SARS-CoV-2 NSP14 RNA cap methyltransferaseCindy Meyer, Aitor Garzia, Michael W Miller, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Acta Crystallographica. Section D, Biological Crystallography|September 21, 2007
Conformational switches in winged-helix domains 1 and 2 of bacterial translation elongation factor SelBOleg Ganichkin, Markus C Wahl
Nature Communications|October 28, 2022
Chemical space docking enables large-scale structure-based virtual screening to discover ROCK1 kinase inhibitorsPaul Beroza, James J Crawford, Oleg Ganichkin, et al.
Mabs|October 15, 2024
CD200R1 immune checkpoint blockade by the first-in-human anti-CD200R1 antibody 23ME-00610: molecular mechanism and engineering of a surrogate antibodyCristina Melero, S Jimmy Budiardjo, Anahita Daruwalla, et al.
The Journal of Biological Chemistry|October 8, 2023
Biophysical and structural characterization of the impacts of MET phosphorylation on tepotinib bindingUlrich Grädler, Daniel Schwarz, Ansgar Wegener, et al.
ACS Medicinal Chemistry Letters|September 17, 2025
Discovery of Novel Isofunctional SARS-CoV‑2 NSP14 RNA Cap Methyltransferase Inhibitors by Structure-Based Virtual ScreeningCindy Meyer, Mayako Michino, David J Huggins, et al.
Nature Methods|August 4, 2015
ProteoPlex: stability optimization of macromolecular complexes by sparse-matrix screening of chemical spaceAshwin Chari, David Haselbach, Jan-Martin Kirves, et al.
Journal of Medicinal Chemistry|September 5, 2025
Discovery, Optimization, and Evaluation of Non-Nucleoside SARS-CoV-2 NSP14 InhibitorsMichael W Miller, Cindy Meyer, Aitor Garzia, et al.
Nature|December 11, 2024
Small-molecule inhibition of SARS-CoV-2 NSP14 RNA cap methyltransferaseCindy Meyer, Aitor Garzia, Michael W Miller, et al.
Pageof 1